The Market Reports

Synopsis
The global market for Cardiovascular Interventional Devices was estimated to be worth US$ 13810 million in 2024 and is forecast to a readjusted size of US$ 23200 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Cardiovascular interventional devices are medical instruments designed to assist in the diagnosis, treatment, and management of cardiovascular diseases through minimally invasive procedures. These devices are primarily used in interventions that address conditions such as coronary artery disease, peripheral artery disease, and heart valve disorders. Common types of cardiovascular interventional devices include stents, angioplasty balloons, guidewires, catheters, and embolization devices, which are used to open blocked arteries, place stents, or deliver targeted treatments without the need for invasive surgery. These devices have revolutionized cardiovascular care, enabling safer, more efficient treatments with shorter recovery times compared to traditional open-heart surgery.
The cardiovascular interventional devices market is primarily driven by the increasing global prevalence of cardiovascular diseases (CVDs), including coronary artery disease, heart failure, and peripheral artery disease. As the global population ages and lifestyle-related factors such as poor diet, lack of exercise, and smoking continue to contribute to the rise in cardiovascular conditions, the demand for minimally invasive treatments grows. Interventional procedures like angioplasty, stenting, and catheter-based diagnostics have become more common due to their lower risk, shorter recovery times, and reduced need for hospitalization. Furthermore, advancements in technology, including the development of bioabsorbable stents, improved imaging systems, and next-generation guidewires, continue to drive the market by offering safer, more efficient treatment options.
However, the cardiovascular interventional devices market faces challenges, such as the high cost of advanced devices and procedures, which can limit accessibility, particularly in developing countries or healthcare systems with budget constraints. Additionally, the complexity of these procedures requires specialized training and expertise, which may not be readily available in all healthcare settings, especially in low-resource regions. Despite the benefits of minimally invasive interventions, complications like stent restenosis, thrombosis, and device malfunctions continue to pose risks to patients, affecting overall treatment success. Furthermore, regulatory hurdles and lengthy approval processes for new devices can slow innovation and increase the time it takes for new technologies to reach the market.
The global top 5 players hold a market share over 70% in 2024. The key players are Boston Scientific Corporation, ABBOTT LABORATORIES, Medtronic, etc.
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Interventional Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiovascular Interventional Devices by region & country, by Type, and by Application.
The Cardiovascular Interventional Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Interventional Devices.
Market Segmentation
By Company
Boston Scientific Corporation
ABBOTT
Medtronic
Terumo
NIPRO
B. Braun
Cook medical
Microport
Lepu medical
JW Medical
ASAHI INTECC
Kaneka Corporation
Sinomed
LifeTech Scientific Corporation
Gore
Acotec
Biotronik
Cordis
Segment by Type
Coronary Artery Stent
PTCA Balloon Catheter
Thread
Other
Segment by Application
Angina Pectoris
Myocardial Infarction,
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiovascular Interventional Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiovascular Interventional Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiovascular Interventional Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index